Hospital or health organisation · founded 1889
Mayo Clinic in Arizona
Scottsdale, United States · mayoclinic.org/patient-visitor-guide/arizona
Part of Mayo Clinic
- Citations, last 5 years
- 70k
- Works, last 5 years
- 10.5k
- h-index
- 588
- Scientists listed
- 300
- Grants since 2016
- 386
Grants received
2018–2023 · career development · K01
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
Bolni Marius Nagalo · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2023 · research · R01
Credentialing a Genetically Engineered Clinically-Relevant Mouse Model of Multiple Myeloma
Marta Chesi · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2023 · program · P01
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma
Lisa Rimsza · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2021 · career development · K01
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
Bolni Marius Nagalo · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2023 · research · R01
Credentialing a Genetically Engineered Clinically-Relevant Mouse Model of Multiple Myeloma
Marta Chesi · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2024 · research · R01
Credentialing a Genetically Engineered Clinically-Relevant Mouse Model of Multiple Myeloma
Marta Chesi · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2021 · research · R01
Universal positive allosteric modulators of CCK1R without intrinsic agonist activity for the treatment of obesity
Laurence J Miller · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2023 · program · P01
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma
Andrew Lewis Feldman · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2021 · research · R21
Step down of asthma biologics in real-world practice settings
Matthew A Rank · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2023 · career development · K01
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
Bolni Marius Nagalo · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2022 · research · R01
Treatment of arterial aneurysms using an injectable biomaterial
Ali Khademhosseini · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2025 · research · R33
Increasing Adherence to Pulmonary Rehabilitation after COPD-related Hospitalizations (Transfer)
Roberto Pablo Benzo · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2024 · program · P01
Molecular Classification of Anaplastic Large Cell Lymphoma
Andrew Lewis Feldman · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2024 · program · P01
Molecular Pathogenesis of Two Newly Defined Major Subgroups of PTCL
Javeed Iqbal · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2024 · program · P01
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma
Elias Campo · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2024 · program · P01
Administrative Core
Lisa Rimsza · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2024 · program · P01
Pathology Core
James R Cook · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2024 · program · P01
Molecular Dissection of Aggressive B-Cell Lymphomas
David William Scott · Mayo Clinic in Arizona · funded by National Institutes of Health
2018–2024 · program · P01
Preclinical Models and Therapeutics Core
Giorgio Inghirami · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2023 · cooperative agreement · U01
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
Leland Hu · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2022 · cooperative agreement · UH3
Development of Mantle Cell Lymphoma Proliferation Signature Assay
Lisa Rimsza · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2022 · cooperative agreement · UH3
Development of Mantle Cell Lymphoma Proliferation Signature Assay
Lisa Rimsza · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
Leland Hu · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2021 · research · R00
Metabolic reprogramming in pluripotent induction and cardiac lineage specificatio
Clifford D Folmes · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2022 · research · R01
Gastrointestinal Safety of Antithrombotic Drug Regimens
Neena S Abraham · Mayo Clinic in Arizona · funded by Agency for Healthcare Research and Quality
2017–2023 · cooperative agreement · U54
Overcoming Drug Resistance in Multiple Myeloma
Peter Leif Bergsagel · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2020 · research · R01
Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure
Laurence J Miller · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2022 · research · R01
Targeted chemotherapy delivery and capture
Ali Khademhosseini · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2025 · research · R01
Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure
Robert Ardecky · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2020 · research · R01
Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure
Laurence J Miller · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2023 · research · R01
Hemorrhage control in the irreversible anticoagulated patient
Rahmi Oklu · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2020 · research · R00
Metabolic reprogramming in pluripotent induction and cardiac lineage specificatio
Clifford D Folmes · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2022 · cooperative agreement · U54
Overcoming Drug Resistance in Multiple Myeloma
Peter Leif Bergsagel · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2021 · research · R01
Gastrointestinal Safety of Antithrombotic Drug Regimens
Neena S Abraham · Mayo Clinic in Arizona · funded by Agency for Healthcare Research and Quality
2017–2019 · cooperative agreement · UH2
Development of Mantle Cell Lymphoma Proliferation Signature Assay
Lisa Rimsza · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2020 · research · R21
Imaging Functionally Distinct Eosinophil Subtypes Within Tissue Biopsies Using Gene Expression Profiling and an In Situ Hybridization Approach based on a Concurrent Multiple RNA Targeting Strategy
Elizabeth A Jacobsen · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2022 · research · R01
Hemorrhage control in the irreversible anticoagulated patient
Rahmi Oklu · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2023 · cooperative agreement · U01
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
Leland Hu · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
Leland Hu · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2021 · research · R01
Gastrointestinal Safety of Antithrombotic Drug Regimens
Neena S Abraham · Mayo Clinic in Arizona · funded by Agency for Healthcare Research and Quality